ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,127.79
      1.26%
      US Tech 100
      17,446.00
      2.17%
      Dow Jones
      38,675.68
      1.18%
      Brent Oil
      82.765
      0.00%
      Bitcoin
      64,276.54
      0.60%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Scilex Holding Company (SCLX)

      7. Scilex Holding Company (SCLX) News

      SCLX

      Scilex (SCLX)

      Scilex Holding Company
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:SCLX
      DateTimeSourceHeadlineSymbolCompany
      04/25/20244:01PMGlobeNewswire Inc.Scilex Holding Company Announces Closing of $15 Million Registered Direct OfferingNASDAQ:SCLXScilex Holding Company
      04/24/20248:00AMGlobeNewswire Inc.Scilex Holding Company Announces $15 Million Registered Direct OfferingNASDAQ:SCLXScilex Holding Company
      04/16/20249:00AMGlobeNewswire Inc.Scilex Holding Company Provides Certain Preliminary Unaudited Financial Results For Gross and Net Sales for ZTlido® for the First Quarter 2024; Implements Planned 2024 Commercial Ramp for Additional Opioid Sparing Product and Reduction of R&D and Other AdNASDAQ:SCLXScilex Holding Company
      04/09/20249:00AMGlobeNewswire Inc.Scilex Holding Company Announces Launching of Co-Pay Programs for Both ZTlido® and ELYXYB® for Commercially Insured Patients and the addition of ELYXYB® to a Multi-State Medicaid Pharmaceutical Purchasing Group to Its Purchasing PoolNASDAQ:SCLXScilex Holding Company
      03/27/20249:00AMGlobeNewswire Inc.Scilex Holding Company Announces that the U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Stock Previously Distributed by Sorrento to its Stockholders as a DividendNASDAQ:SCLXScilex Holding Company
      03/21/20249:30AMGlobeNewswire Inc.Scilex Holding Company Announces New Out-of-Pocket Costs for Commercially Insured PatientsNASDAQ:SCLXScilex Holding Company
      03/20/202411:00AMGlobeNewswire Inc.Scilex Holding Company Announces Seeking Approval from the FDA for Modification of the Gloperba® Label to Provide Specific Dosing Guidance for Patients with Renal Impairment and Other Circumstances Where Dose Adjustment is NeededNASDAQ:SCLXScilex Holding Company
      03/20/20249:00AMGlobeNewswire Inc.Scilex Holding Company Announces a Settlement Agreement with Takeda Pharmaceuticals to Resolve the Paragraph IV Patent Infringement Lawsuit Relating to Scilex’s Filing of a sNDA with the FDA Seeking to Expand the Label for its FDA-Approved Liquid ColchicNASDAQ:SCLXScilex Holding Company
      03/19/20249:00AMGlobeNewswire Inc.Scilex Holding Company Announces Repayment in Full of the Remaining Balance of Convertible Debentures and Early Payment of the Senior Secured Promissory Note, Paving the Way for Future Growth and InnovationNASDAQ:SCLXScilex Holding Company
      03/18/20249:00AMGlobeNewswire Inc.Scilex Holding Company Provides Responses to Product Composition Questions Related to its ELYXYB® Patent in Canada for a New Drug Submission Under Review by Health Canada for the Approval of ELYXYB® for Acute Treatment of Migraine With or Without Aura inNASDAQ:SCLXScilex Holding Company
      03/15/20242:45PMGlobeNewswire Inc.Scilex Holding Announces Issuance of Halal Certification for its ZTlido® product by Circle H International, Inc.NASDAQ:SCLXScilex Holding Company
      03/15/20249:00AMGlobeNewswire Inc.Scilex Holding Company’s Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc., Entered into a Definitive Mutual Release and Settlement Agreement with Virpax Pharmaceuticals, Inc. Relating to the Previously Announced Term Sheet with Virpax in Respect of SNASDAQ:SCLXScilex Holding Company
      03/11/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SCLXScilex Holding Company
      03/05/20244:22PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:SCLXScilex Holding Company
      03/05/20244:20PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SCLXScilex Holding Company
      03/05/20244:17PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SCLXScilex Holding Company
      03/05/20244:16PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SCLXScilex Holding Company
      03/05/20244:13PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SCLXScilex Holding Company
      03/05/20244:12PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SCLXScilex Holding Company
      03/05/20244:01PMGlobeNewswire Inc.Scilex Holding Company Announces Closing of $10 Million Bought Deal OfferingNASDAQ:SCLXScilex Holding Company
      03/05/20249:00AMGlobeNewswire Inc.Scilex Holding Company Sets Launch Price of $595 per 150ml bottle of Gloperba®, its First and Only Liquid Oral Version of the Anti-Gout Medicine Colchicine Indicated for the Prophylaxis of Painful Gout Flares in Adults; Expected Plans to Launch in the FirNASDAQ:SCLXScilex Holding Company
      03/04/20244:02PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:SCLXScilex Holding Company
      03/04/20249:00AMGlobeNewswire Inc.Scilex Holding Company Launches New Website to Showcase Growing Portfolio of Non-Opioid Products and Pipeline Information UpdatesNASDAQ:SCLXScilex Holding Company
      03/02/20243:25PMGlobeNewswire Inc.Scilex Holding Company Announces that the Official Committee of Unsecured Creditors of Sorrento Therapeutics, Inc., has Filed a Motion with the U.S. Bankruptcy Court to Extend the Lockup Period on Shares of Scilex Stock Previously Distributed by Sorrento tNASDAQ:SCLXScilex Holding Company
      03/01/20246:17AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SCLXScilex Holding Company
      03/01/20246:14AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SCLXScilex Holding Company
      03/01/20246:11AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SCLXScilex Holding Company
      03/01/20246:07AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SCLXScilex Holding Company
      02/29/20245:32PMGlobeNewswire Inc.Scilex Holding Company Announces $10 Million Bought Deal OfferingNASDAQ:SCLXScilex Holding Company
      02/29/20245:24PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SCLXScilex Holding Company
       Showing the most relevant articles for your search:NASDAQ:SCLX